Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.GlobeNewsWire • 09/01/20
If You Like Attractively Valued Blue-Chips, You'll Love These 7 Dividend Growth StocksSeeking Alpha • 08/19/20
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of Principia Biopharma Inc. to SanofiNewsfile Corp • 08/17/20
PRINCIPIA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PRNB and Encourages Investors to Contact the FirmBusiness Wire • 08/17/20
Oita Chuo Pacific Management Comments on Sanofi as They Agree to Acquire U.S. Biotech Firm Principia BiopharmaBusiness Wire • 08/17/20
Sanofi To Acquire Partner Principia Biopharma, Expand MS Treatment EffortsInvestors Business Daily • 08/17/20
The U.S. has already invested billions on potential coronavirus vaccines. Here's where the deals standCNBC • 08/14/20